| 1 | Impact of Cancer Stem Cells and Cancer Stem Cell-Driven Drug Resiliency in Lung Tumor: Options in Sight. 2022;14:267 doi: 10.3390/cancers14020267 |
| 2 | Multidrug Resistance in Cancer Cells: Focus on a Possible Strategy Plan to Address Colon Carcinoma Cells. 2022;12:811 doi: 10.3390/life12060811 |
| 3 | Transporter-mediated Natural Product-Drug Interactions. 2023;89:119 doi: 10.1055/a-1803-1744 |
| 4 | Sex Differences in Intestinal P-Glycoprotein Expression in Wistar versus Sprague Dawley Rats. 2022;14:1030 doi: 10.3390/pharmaceutics14051030 |
| 5 | New Dual P-Glycoprotein (P-gp) and Human Carbonic Anhydrase XII (hCA XII) Inhibitors as Multidrug Resistance (MDR) Reversers in Cancer Cells. 2022;65:14655 doi: 10.1021/acs.jmedchem.2c01175 |
| 6 | ABCG2/BCRP transport mechanism revealed through kinetically excited targeted molecular dynamics simulations. 2022;20:4195 doi: 10.1016/j.csbj.2022.07.035 |
| 7 | Involvement of Multidrug Resistance Modulators in the Regulation of the Mitochondrial Permeability Transition Pore. 2022;12:890 doi: 10.3390/membranes12090890 |
| 8 | Advances in Hydrogel-Based Microfluidic Blood–Brain-Barrier Models in Oncology Research. 2022;14:993 doi: 10.3390/pharmaceutics14050993 |
| 9 | Phytol and Heptacosane Are Possible Tools to Overcome Multidrug Resistance in an In Vitro Model of Acute Myeloid Leukemia. 2022;15:356 doi: 10.3390/ph15030356 |
Cancer Drug Resistance
